Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 500

1.

Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY.

N Engl J Med. 2002 Oct 10;347(15):1151-60.

2.

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.

Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY.

J Immunol. 2003 Sep 15;171(6):3262-9.

3.

Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals.

Goo J, Ji JH, Jeon H, Kim MJ, Jeon SY, Cho MY, Lee SH, Choi EH.

Pediatr Dermatol. 2010 Jul-Aug;27(4):341-8. doi: 10.1111/j.1525-1470.2010.01122.x.

PMID:
20653851
4.

Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy.

Gambichler T, Skrygan M, Tomi NS, Altmeyer P, Kreuter A.

Br J Dermatol. 2006 Dec;155(6):1275-8.

PMID:
17107401
5.

Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.

Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A.

Int Arch Allergy Immunol. 2008;147(1):17-24. doi: 10.1159/000128582. Epub 2008 Apr 30.

PMID:
18446049
6.

Expression of LL-37, human beta defensin-2, and CCR6 mRNA in patients with psoriasis vulgaris.

Li D, Li J, Duan Y, Zhou X.

J Huazhong Univ Sci Technolog Med Sci. 2004;24(4):404-6.

PMID:
15587410
7.

Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus.

Gambichler T, Skrygan M, Tigges C, Kobus S, Gläser R, Kreuter A.

Br J Dermatol. 2009 Nov;161(5):1136-42. doi: 10.1111/j.1365-2133.2009.09273.x. Epub 2009 Apr 30.

PMID:
19558556
8.

Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3.

Kisich KO, Carspecken CW, Fiéve S, Boguniewicz M, Leung DY.

J Allergy Clin Immunol. 2008 Jul;122(1):62-8. doi: 10.1016/j.jaci.2008.04.022. Epub 2008 Jun 5.

PMID:
18538383
9.

Mechanism of HBD-3 deficiency in atopic dermatitis.

Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, Girolomoni G, Leung DY.

Clin Immunol. 2006 Dec;121(3):332-8. Epub 2006 Oct 2.

PMID:
17015038
10.

Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases.

Kim JE, Kim BJ, Jeong MS, Seo SJ, Kim MN, Hong CK, Ro BI.

J Korean Med Sci. 2005 Aug;20(4):649-54.

11.

Expression of human beta-defensins in patients with mycosis fungoides.

Gambichler T, Skrygan M, Appelhans C, Tomi NS, Reinacher-Schick A, Altmeyer P, Kreuter A.

Arch Dermatol Res. 2007 Jul;299(4):221-4. Epub 2007 Apr 6.

PMID:
17415576
12.

Dynamic alteration of human beta-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin.

Huh WK, Oono T, Shirafuji Y, Akiyama H, Arata J, Sakaguchi M, Huh NH, Iwatsuki K.

J Mol Med (Berl). 2002 Oct;80(10):678-84. Epub 2002 Sep 19.

PMID:
12395153
13.

Antimicrobial peptides in health and disease.

Zasloff M.

N Engl J Med. 2002 Oct 10;347(15):1199-200. No abstract available.

PMID:
12374882
14.

Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.

Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM.

Oral Microbiol Immunol. 2009 Oct;24(5):353-60. doi: 10.1111/j.1399-302X.2009.00512.x.

PMID:
19702947
15.

Correlation between beta-defensin expression and induction profiles in gingival keratinocytes.

Joly S, Organ CC, Johnson GK, McCray PB Jr, Guthmiller JM.

Mol Immunol. 2005 May;42(9):1073-84. Epub 2004 Dec 15.

PMID:
15829297
16.

Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.

Jensen JM, Ahrens K, Meingassner J, Scherer A, Bräutigam M, Stütz A, Schwarz T, Fölster-Holst R, Harder J, Gläser R, Proksch E.

Exp Dermatol. 2011 Oct;20(10):783-8. doi: 10.1111/j.1600-0625.2011.01322.x. Epub 2011 Jun 24.

PMID:
21707760
17.

Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis.

Stryjewski ME, Hall RP, Chu VH, Kanafani ZA, O'Riordan WD, Weinstock MS, Stienecker RS, Streilein R, Dorschner RA, Fowler VG Jr, Corey GR, Gallo RL.

J Infect Dis. 2007 Nov 1;196(9):1425-30. Epub 2007 Sep 27.

18.

Malassezia furfur induces the expression of beta-defensin-2 in human keratinocytes in a protein kinase C-dependent manner.

Donnarumma G, Paoletti I, Buommino E, Orlando M, Tufano MA, Baroni A.

Arch Dermatol Res. 2004 Apr;295(11):474-81. Epub 2004 Feb 12.

PMID:
14963722
19.

Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin.

Hau CS, Kanda N, Noda S, Tatsuta A, Kamata M, Shibata S, Asano Y, Sato S, Watanabe S, Tada Y.

Am J Pathol. 2013 May;182(5):1705-17. doi: 10.1016/j.ajpath.2013.01.044. Epub 2013 Mar 15.

PMID:
23499548
20.

Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.

Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H.

J Dermatol Sci. 2005 Nov;40(2):123-32. Epub 2005 Jun 15.

PMID:
15963694
Items per page

Supplemental Content

Write to the Help Desk